Society for Neuroscience Annual Meeting 2001
Post-Conference News: Oligomers, Protofibrils, and Fibrils—They Are All Bad Post-Conference News
6052 RESULTS
You searched all-news/Landhuis
Sort By:
Post-Conference News: Oligomers, Protofibrils, and Fibrils—They Are All Bad Post-Conference News
2016 news). “With all of the new tools and theories in development, I believe we are at a turning point
and Other News of Trial Tribulations Paris: More Trial News, Mixed at Best Paris: President and All
Research News New York City-based Bristol-Myers Squibb recently announced that it will halt all
Research News Eli Lilly and Company announced yesterday that they have terminated the Phase
Research News Although the most common genetic cause of familial Parkinson’s, LRRK2 has eluded
Community News Elan’s Alzheimer immunotherapy program (AIP) has gotten a booster. The company
Geneva: At Springfield Meeting, Soul-Searching About Dearth of Drugs Geneva: Biomarker News
in marked contrast to a public perception of all-failure-all-the-time in Alzheimer disease trials.
reaching all the way back to a person’s youth (see ARF related news story; ARF news story). A five-year
Research News Before the business of 2018 consumes all your brain power, take some time to reflect
Research News An antisense oligonucleotide knocked down levels of the mutant huntingtin protein in
Research News Missed last Tuesday’s Science Times? Go fish it out of the recycling bin. The New
Community News The U.S. National Academy of Medicine announced the election of 90 new regular
news from all of this seems to be Snuppy, the world’s first cloned dog. The investigation committee at